Your browser doesn't support javascript.
loading
Gain-of-function CEBPE mutation causes noncanonical autoinflammatory inflammasomopathy.
Göös, Helka; Fogarty, Christopher L; Sahu, Biswajyoti; Plagnol, Vincent; Rajamäki, Kristiina; Nurmi, Katariina; Liu, Xiaonan; Einarsdottir, Elisabet; Jouppila, Annukka; Pettersson, Tom; Vihinen, Helena; Krjutskov, Kaarel; Saavalainen, Päivi; Järvinen, Asko; Muurinen, Mari; Greco, Dario; Scala, Giovanni; Curtis, James; Nordström, Dan; Flaumenhaft, Robert; Vaarala, Outi; Kovanen, Panu E; Keskitalo, Salla; Ranki, Annamari; Kere, Juha; Lehto, Markku; Notarangelo, Luigi D; Nejentsev, Sergey; Eklund, Kari K; Varjosalo, Markku; Taipale, Jussi; Seppänen, Mikko R J.
Affiliation
  • Göös H; Institute of Biotechnology, HiLIFE, University of Helsinki, Helsinki, Finland.
  • Fogarty CL; Folkhälsan Research Center, Helsinki, Finland; Abdominal Center Nephrology, University of Helsinki and Helsinki University Hospital, Helsinki, Finland; Diabetes & Obesity Research Program, Research Program's Unit, University of Helsinki, Helsinki, Finland; Institute of Clinical Medicine, Univers
  • Sahu B; Research Programs Unit, Genome-Scale Biology, Biomedicum Helsinki, University of Helsinki, Helsinki, Finland.
  • Plagnol V; University College London Genetics Institute, University College London, London, United Kingdom.
  • Rajamäki K; Clinicum, Faculty of Medicine, University of Helsinki, Helsinki, Finland.
  • Nurmi K; Clinicum, Faculty of Medicine, University of Helsinki, Helsinki, Finland.
  • Liu X; Institute of Biotechnology, HiLIFE, University of Helsinki, Helsinki, Finland.
  • Einarsdottir E; Folkhälsan Institute of Genetics, Helsinki, Finland; Department of Biosciences and Nutrition, Karolinska Institutet, Stockholm, Sweden; Research Programs Unit, Molecular Neurology, University of Helsinki, Helsinki, Finland.
  • Jouppila A; Helsinki University Hospital Research Institute, Helsinki, Finland.
  • Pettersson T; Clinicum, Faculty of Medicine, University of Helsinki, Helsinki, Finland; Department of Internal Medicine and Rehabilitation, Helsinki University Hospital, Helsinki, Finland.
  • Vihinen H; Electron Microscopy Unit, Institute of Biotechnology, University of Helsinki, Helsinki, Finland.
  • Krjutskov K; Department of Biosciences and Nutrition, Karolinska Institutet, Stockholm, Sweden; Helsinki University Hospital Research Institute, Helsinki, Finland; Competence Centre on Health Technologies, Tartu, Estonia.
  • Saavalainen P; Research Programs Unit, Immunobiology, University of Helsinki, Helsinki, Finland; Department of Medical and Clinical Genetics, University of Helsinki, Helsinki, Finland.
  • Järvinen A; Adult Immunodeficiency Unit, Infectious Diseases, Inflammation Center, University of Helsinki and Helsinki University Hospital, Helsinki, Finland.
  • Muurinen M; Folkhälsan Institute of Genetics, Helsinki, Finland; Research Programs Unit, Molecular Neurology, University of Helsinki, Helsinki, Finland.
  • Greco D; Institute of Biotechnology, HiLIFE, University of Helsinki, Helsinki, Finland; Faculty of Medicine and Life Sciences & Institute of Biosciences and Medical Technology, University of Tampere, Tampere, Finland.
  • Scala G; Institute of Biotechnology, HiLIFE, University of Helsinki, Helsinki, Finland; Faculty of Medicine and Life Sciences & Institute of Biosciences and Medical Technology, University of Tampere, Tampere, Finland.
  • Curtis J; Department of Medicine, University of Cambridge, Cambridge, United Kingdom.
  • Nordström D; Clinicum, Faculty of Medicine, University of Helsinki, Helsinki, Finland; Department of Rheumatology, Inflammation Center, University of Helsinki and Helsinki University Hospital, Helsinki, Finland.
  • Flaumenhaft R; Beth Israel Deaconess Medical Center, Department of Medicine, Harvard Medical School, Boston, Mass.
  • Vaarala O; Pediatric Research Center, University of Helsinki and Helsinki University Hospital, Helsinki, Finland; Respiratory, Inflammation and Autoimmunity, Innovative Medicine, AstraZeneca, Mölndal, Sweden.
  • Kovanen PE; Department of Pathology, University of Helsinki, and HUSLAB, Helsinki University Hospital, Helsinki, Finland.
  • Keskitalo S; Institute of Biotechnology, HiLIFE, University of Helsinki, Helsinki, Finland.
  • Ranki A; Department of Dermatology, Allergology and Venereal Diseases, Inflammation Center, University of Helsinki and Helsinki University Hospital, Helsinki, Finland.
  • Kere J; Folkhälsan Institute of Genetics, Helsinki, Finland; Department of Biosciences and Nutrition, Karolinska Institutet, Stockholm, Sweden; Research Programs Unit, Molecular Neurology, University of Helsinki, Helsinki, Finland; School of Basic and Medical Biosciences, King's College London, Guy's Hospit
  • Lehto M; Folkhälsan Research Center, Helsinki, Finland; Abdominal Center Nephrology, University of Helsinki and Helsinki University Hospital, Helsinki, Finland; Diabetes & Obesity Research Program, Research Program's Unit, University of Helsinki, Helsinki, Finland.
  • Notarangelo LD; Laboratory of Clinical Immunology and Microbiology, National Institute of Allergy and Infectious Diseases, National Institutes of Health, Bethesda, Md.
  • Nejentsev S; Department of Medicine, University of Cambridge, Cambridge, United Kingdom.
  • Eklund KK; Clinicum, Faculty of Medicine, University of Helsinki, Helsinki, Finland; Department of Rheumatology, Inflammation Center, University of Helsinki and Helsinki University Hospital, Helsinki, Finland; Orton Orthopaedic Hospital and Research Institute, Invalid Foundation, Helsinki, Finland.
  • Varjosalo M; Institute of Biotechnology, HiLIFE, University of Helsinki, Helsinki, Finland.
  • Taipale J; Research Programs Unit, Genome-Scale Biology, Biomedicum Helsinki, University of Helsinki, Helsinki, Finland; Division of Functional Genomics and Systems Biology, Department of Medical Biochemistry and Biophysics, Karolinska Institutet, Solna, Sweden; Department of Biochemistry, Cambridge University
  • Seppänen MRJ; Adult Immunodeficiency Unit, Infectious Diseases, Inflammation Center, University of Helsinki and Helsinki University Hospital, Helsinki, Finland; Rare Diseases Center and Pediatric Research Center, Children's Hospital, University of Helsinki and Helsinki University Hospital, Helsinki, Finland. Elec
J Allergy Clin Immunol ; 144(5): 1364-1376, 2019 11.
Article in En | MEDLINE | ID: mdl-31201888
BACKGROUND: CCAAT enhancer-binding protein epsilon (C/EBPε) is a transcription factor involved in late myeloid lineage differentiation and cellular function. The only previously known disorder linked to C/EBPε is autosomal recessive neutrophil-specific granule deficiency leading to severely impaired neutrophil function and early mortality. OBJECTIVE: The aim of this study was to molecularly characterize the effects of C/EBPε transcription factor Arg219His mutation identified in a Finnish family with previously genetically uncharacterized autoinflammatory and immunodeficiency syndrome. METHODS: Genetic analysis, proteomics, genome-wide transcriptional profiling by means of RNA-sequencing, chromatin immunoprecipitation (ChIP) sequencing, and assessment of the inflammasome function of primary macrophages were performed. RESULTS: Studies revealed a novel mechanism of genome-wide gain-of-function that dysregulated transcription of 464 genes. Mechanisms involved dysregulated noncanonical inflammasome activation caused by decreased association with transcriptional repressors, leading to increased chromatin occupancy and considerable changes in transcriptional activity, including increased expression of NLR family, pyrin domain-containing 3 protein (NLRP3) and constitutively expressed caspase-5 in macrophages. CONCLUSION: We describe a novel autoinflammatory disease with defective neutrophil function caused by a homozygous Arg219His mutation in the transcription factor C/EBPε. Mutated C/EBPε acts as a regulator of both the inflammasome and interferome, and the Arg219His mutation causes the first human monogenic neomorphic and noncanonical inflammasomopathy/immunodeficiency. The mechanism, including widely dysregulated transcription, is likely not unique for C/EBPε. Similar multiomics approaches should also be used in studying other transcription factor-associated diseases.
Subject(s)
Key words

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: CCAAT-Enhancer-Binding Proteins / Inflammasomes / Gain of Function Mutation / Immunologic Deficiency Syndromes / Inflammation / Macrophages / Neutrophils Type of study: Etiology_studies / Prognostic_studies Limits: Aged / Female / Humans / Male Language: En Journal: J Allergy Clin Immunol Year: 2019 Document type: Article Affiliation country: Country of publication:

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: CCAAT-Enhancer-Binding Proteins / Inflammasomes / Gain of Function Mutation / Immunologic Deficiency Syndromes / Inflammation / Macrophages / Neutrophils Type of study: Etiology_studies / Prognostic_studies Limits: Aged / Female / Humans / Male Language: En Journal: J Allergy Clin Immunol Year: 2019 Document type: Article Affiliation country: Country of publication: